## Abbreviations
Targeted Therapy for Autoimmune Diseases Based on Multi-functional Frame Nucleic Acid System: Blocking TNF-\(\alpha\)-NF-\(\kappa\)B Signaling and Mediating Macrophage Polarization. _Chem. Eng. J._**2023**, _454_, 140399. [CrossRef]* Collins et al. (2012) Collins, S.M. ; Surette, M.; Bercik, P. The Interplay between the Intestinal Microbiota and the Brain. _Nat. Rev. Microbiol._**2012**, _10_, 735-742. [CrossRef]
* Cox and Weiner (2018) Cox, L.M. ; Weiner, H.L. Microbiota Signaling Pathways That Influence Neurologic Disease. _Neurotherapeutics_**2018**, _15_, 135-145. [CrossRef]
* Cryan and Dinn (2012) Cryan, J.F. ; Dinn, T.G. Mind-Altering Microorganisms: The Impact of the Gut Microbiota on Brain and Behaviour. _Nat. Rev. Neurosci._**2012**, _13_, 701-712. [CrossRef]
* Chen et al. (2021) Chen, Y.; Xu, J.; Chen, Y. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders. _Nutrients_**2021**, _13_, 2099. [CrossRef]
* Cryan et al. (2019) Cryan, J.F. ; O'Riordan, K.J. ; Sandhu, K.; Peterson, V.; Dinan, T.G. The Gut Microbiome in Neurological Disorders. _Lancet Neurol._**2019**, 19. [CrossRef]
* Tang et al. (2017) Tang, H.-L.; Zhang, G.; Ji, N.-N.; Du, L.; Chen, B.-B. ; Hua, R.; Zhang, Y.-M. Toll-like Receptor 4 in Paraventricular Nucleus Mediates Visceral Hypersensitivity Induced by Maternal Separation. _Front. Pharmacol._**2017**, \(8\), 309. [CrossRef] [PubMed]
* Xi et al. (2022) Xi, M.; Zhao, P.; Li, F.; Bao, H.; Ding, S.; Ji, L.; Yan, J. MicroRNA-16 Inhibits the TLR4/NF-KB Pathway and Maintains Tight Junction Integrity in Irritable Bowel Syndrome with Diarrhea. _J. Biol. Chem._**2022**, _298_, 102461. [CrossRef] [PubMed]
* Wan et al. (2024) Wan, X.; Wang, L.; Wang, Z.; Wan, C. Toll-like Receptor 4 Plays a Vital Role in Irritable Bowel Syndrome: A Scoping Review. _Front. Immunol._**2024**, _15_, 1490653. [CrossRef] [PubMed]
* Giambra et al. (2015) Giambra, V.; Pagliari, D.; Rio, P.; Totti, B.; Di Nunzio, C.; Bosi, A.; Giaroni, C.; Gasbarrini, A.; Gambassi, G.; Cianci, R. Gut Microbiota, Inflammatory Bowel Disease, and Cancer: The Role of Guardians of Innate Immunity. _Cells_**2023**, _12_, 2654. [CrossRef]
* Martin-Subero et al. (2015) Martin-Subero, M.; Anderson, G.; Kanchanatanwan, B.; Berk, M.; Maes, M. Comorbidity between Depression and Inflammatory Bowel Disease Explained by Immune-Inflammatory, Oxidative, and Nitrosative Stress; Tryptophan Catabolite; and Gut-Brain Pathways. _CNS Spectr._**2015**, _21_, 184-198. [CrossRef]
* He et al. (2018) He, F.; Wu, C.; Li, P.; Li, N.; Zhang, D.; Zhu, Q.; Ren, W.; Peng, Y. Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation. _BioMed Res. Int._**2018**, _2018_, 9171905. [CrossRef]
* Gershon (2013) Gershon, M.D. 5-Hydroxyryptamine (Serotonin) in the Gastrointestinal Tract. _Curr. Opin. Endocrinol. Diabetes Obes._**2013**, _20_, 14-21. [CrossRef]
* Lamas et al. (2016) Lamas, B.; Richard, M.L. ; Leducq, V.; Pham, H.-P.; Michel, M.-L.; Da Costa, G.; Bridonneau, C.; Jegou, S.; Hoffmann, T.W. ; Natividad, J.M. ; et al. CARD9 Impacts Colitis by Altering Gut Microbiota Metabolism of Tryptophan into Aryl Hydrocarbon Receptor Ligands. _Nat. Med._**2016**, _22_, 598-605. [CrossRef]
* Etienne-Mesmin et al. (2017) Etienne-Mesmin, L.; Chassaing, B.; Gewritz, A.T. Tryptophan: A Gut Microbiota-Derived Metabolites Regulating Inflammation. _World J. Gastrointestinal. Pharmacol. Ther._**2017**, \(8\), 7. [CrossRef]
* Yu et al. (2016) Yu, F.-Y. ; Huang, S.-G.; Zhang, H.-Y. ; Ye, H.; Chi, H.-G.; Zou, Y.; Lv, R.-X. ; Zheng, X.-B. Comparison of 5-Hydroxytryptophan Signaling Pathway Characteristics in Diarrhea-Predominant Irritable Bowel Syndrome and Ulcerative Colitis. _World J. Gastroenterol._**2016**, _22_, 3451-3459. [CrossRef]
* Guseva et al. (2014) Guseva, D.; Holst, K.; Kaine, B.; Meier, M.; Keubler, L.; Glage, S.; Buettner, M.; Bleich, A.; Pabst, O.; Bachmann, O.; et al. Serotonin 5-HT7 Receptor Is Critically Involved in Acute and Chronic Inflammation of the Gastrointestinal Tract. _Inflamm.